In recent years, the cost of intensive care treatment has become increasingly important to managers and medical professionals. In fact, every treatment could be discussed in the context of a cost-benefit analysis. At present, most hospitals have a committee that studies the need for all newly introduced medications and facilities. A cost analysis is usually performed. If SDD is introduced in a hospital, the medical staff and managers may be confronted with the question of its cost and benefits. The purpose of this chapter is to review the current literature relating to the cost of SDD.


Liver Transplant Patient Intensive Care Treatment Selective Digestive Decontamination Multiple Trauma Patient Selective Decontamination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jegers M, Edbrooke DL, Hibbert CL et al (2002) Definitions and methods of cost assessment: an intensivist’s guide. Intensive Care Med 28:680–685PubMedCrossRefGoogle Scholar
  2. 2.
    De Jonge E, Schulz MJ, Spanjaart L et al (2003) Effects of Selective Decontamination of the Digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362:1011–1016PubMedCrossRefGoogle Scholar
  3. 3.
    Abele-Horn M, Dauber A, Bauernfeind A et al (1997) Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med 23:187–195PubMedCrossRefGoogle Scholar
  4. 4.
    Quinio B, Albanese J, Bues-Charbit M et al (1996) Selective decontamination if the digestive tract in multiple trauma. Chest 109:765–772PubMedCrossRefGoogle Scholar
  5. 5.
    Van Nieuwenhoven CA, Buskens E, Bergmans DC, Van Tiel F et al (2004) Oral decontamination is cost-saving in the prevention of ventilator-associated Pneumonia in intensive care units. Crit Care Med 32:126–130PubMedCrossRefGoogle Scholar
  6. 6.
    Korinek AM, Laisne MJ, Nicholas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients. A double-blind, randomised, placebocontrolled study. Crit Care Med 21:1466–1473PubMedCrossRefGoogle Scholar
  7. 7.
    Rocha LA, Martin MJ, Pita S, (1992) Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract: a randomised, double-blind, placebo-controlled study. Intensive Care Med 18:398–404PubMedCrossRefGoogle Scholar
  8. 8.
    Langlois-Karaga A, Bues-Charbit M, Davignon A et al (1995) Selective digestive decontamination in multiple trauma patients: cost and efficacy. Pharm World Sci 17:12–16PubMedCrossRefGoogle Scholar
  9. 9.
    Wiener J, Itokazu G, Nathan C (1995) A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 20:861–867PubMedGoogle Scholar
  10. 10.
    Gastinne H, Wolff M, Delatour F et al (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N. Engl J Med 326:594–599PubMedCrossRefGoogle Scholar
  11. 11.
    Van Enckevort PJ, Zwaveling JH, Bottema JT et al (2001) Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics 19:523–530PubMedCrossRefGoogle Scholar
  12. 12.
    Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients. Crit Care Med 30:1204–1209PubMedCrossRefGoogle Scholar
  13. 13.
    Hellinger WC, Yao JD, Alvarez S et al (2002) A randomised, prospective, double-blind evaluation of selective bowel decontamination in liver transplantation. Transplantation 73:1904–1909PubMedCrossRefGoogle Scholar
  14. 14.
    Stoutenbeek CP, van Saene HKF, Zandstra DF (1996) Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. In: Faist EBAE, Baue AE, Schildberg FW (eds) The immune consequences of trauma, shock and sepsis-mechanisms and therapeutic approaches. Lengerich: Pabst Science Publishers, pp 1055–1066Google Scholar
  15. 15.
    Schardey HM, Joosten U, Finke U et al (1997) Kostensenkung durch Dekontamination zur Prävention der Nahtinsuffizienz nach Gastrectomie. Chirurg 68:416–424PubMedCrossRefGoogle Scholar
  16. 16.
    van der Voort PHJ, van Roon EN, Kampinga GA et al (2004) A before-after study of multiresistance and cost of selective decontamination of the digestive tract. Infection 32:271–277PubMedCrossRefGoogle Scholar
  17. 17.
    Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomized controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 25:63–71PubMedCrossRefGoogle Scholar
  18. 18.
    Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 42:687–693PubMedCrossRefGoogle Scholar
  19. 19.
    Sanchez Garcia M, Cambronero Galache A, Lopez Diaz J et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. Am J Respir Crit Care Med 158:908–916PubMedGoogle Scholar
  20. 20.
    Rolando N, Gimson A, Wade J et al (1993) Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 17:196–201PubMedGoogle Scholar
  21. 21.
    Making health care safer: a critical analysis of patient safety practices 2001. Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Peter H. J. van der Voort
    • 1
  1. 1.Department of Intensive CareOnze Lieve Vrouwe GasthuisAmsterdamThe Netherlands

Personalised recommendations